Prevention of progression in Parkinson’s disease

Although, particularly early in the 1920s, the cleanliness of the Cana- dian milk supply was uneven, public health professionals, the dairy indus- try, and the Federal Department

Upon subsequent identification of the activator protein as a mixture of 14-3-3 proteins [39], access to purified enzymes and specific anti- bodies, it has been shown that all seven

relationship between fatigue and disease severity where somewhat controversy, clinical studies found associations with other non-motor problems such as depression and

Age at onset-dependent rates of disease progression measured by the Unified Parkinson Disease Rating Scale motor score (A) and the Hoehn and Yahr scale (B). For all

3) In study 3 explored depressive symptoms in patients with PD without major depression, i.e. sub-threshold depression, and examined its relationship to other clinical features

The transcript (ENST00000506244) encoding the full-length protein (SNCA-140), showed a trend for reduced relative expression in PD, but this did not reach statistical significance (p

To evaluate the economic burden of a disease can be a problematic task, as the costs are compounded by many different factors. Some may be easy to assess, but in many cases

Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*. Zimprich A, Muller-Myhsok B, Farrer M,